DOI QR코드

DOI QR Code

Oncologic Outcome and Distant Metastasis of Head and Neck Adenoid Cystic Carcinoma

두경부 선낭암종의 예후와 원격 전이

  • Yoon, Hee Soo (Department of Otolaryngology-Head and Neck Surgery, Hanyang University College of Medicine) ;
  • Park, Sang Gyu (Department of Otolaryngology-Head and Neck Surgery, Hanyang University College of Medicine) ;
  • Park, Hae Jin (Department of Radiation Oncology, College of Medicine, Hanyang University) ;
  • Song, Chang Myeon (Department of Otolaryngology-Head and Neck Surgery, Hanyang University College of Medicine) ;
  • Ji, Yong Bae (Department of Otolaryngology-Head and Neck Surgery, Hanyang University College of Medicine) ;
  • Tae, Kyung (Department of Otolaryngology-Head and Neck Surgery, Hanyang University College of Medicine)
  • 윤희수 (한양대학교 의과대학 이비인후-두경부외과학교실) ;
  • 박상규 (한양대학교 의과대학 이비인후-두경부외과학교실) ;
  • 박혜진 (한양대학교 의과대학 방사선종양학교실) ;
  • 송창면 (한양대학교 의과대학 이비인후-두경부외과학교실) ;
  • 지용배 (한양대학교 의과대학 이비인후-두경부외과학교실) ;
  • 태경 (한양대학교 의과대학 이비인후-두경부외과학교실)
  • Received : 2018.10.10
  • Accepted : 2018.11.03
  • Published : 2018.11.30

Abstract

Background/Objectives: Adenoid cystic carcinoma is the second most common salivary carcinoma. It occurs commonly in the submandibular gland, sublingual gland and minor salivary gland. Local recurrence and distant metastasis are the leading cause of death. The aim of this study was to evaluate long-term oncologic outcomes of patients with head and neck adenoid cystic carcinoma focusing on distant metastasis. Materials & Methods: We retrospectively studied 39 patients who were diagnosed with and treated for adenoid cystic carcinoma of the head and neck from December 1996 to May 2018. The clinicopathologic characteristics of patients such as age, sex, primary site and TNM stage, and treatment methods, recurrence and distant metastasis after treatment, survival rate, and treatment method for recurrence were analyzed. Results: Of 39 patients, 18 were males and 21 were females, and the mean age was $5.9{\pm}14.4$ (28-89) years. The most common primary site was oral cavity (12 cases), and followed by sino-nasal cavity (11 cases), parotid gland (5 cases), and etc. For treatment, 17 patients underwent surgery alone, 16 received surgery with postoperative radiation therapy, and 3 patients received radiation therapy only. Three patients refused any further treatments. Recurrence occurred in 15 patients. The most common site of recurrence was the lung. The mean time to recurrence was 31.7 months. The 5 and 10 years' overall survival rate was 79.3% and 74%, respectively. The 2 and 5 years' overall survival rate was 69.6% and 62.6% in patients with distant metastasis. Conclusion: Distant metastasis is an important prognostic factor in adenoid cystic carcinoma, and eventually one third of patients have distant metastasis, especially in the lung. An appropriate treatment for lung metastasis is necessary because some patients with pulmonary metastasis survive for a quite long time.

Keywords

References

  1. Jang S, Patel PN, Kimple RJ, Mcculloch TM. Clinical outcomes and prognostic factors of adenoid cystic carcinoma of the head and neck. Anticancer Res. 2017;37:3045-3052.
  2. Matsuba HM, Spector GJ, Thawley SE, Simpson JR, Mauney M, Pikul FJ. Adenoid cystic salivary gland carcinoma: a histopathologic review of treatment failure patterns. Cancer. 1986;57:519-524. https://doi.org/10.1002/1097-0142(19860201)57:3<519::AID-CNCR2820570319>3.0.CO;2-V
  3. van der Wal JE, Becking AG, Snow GB, van der Waal I. Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up. Head Neck. 2002;24:779-783. https://doi.org/10.1002/hed.10126
  4. Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE. Adenoid cystic carcinoma of the head and neck-a 20 years experience. Int J Oral Maxillofac Surg. 2004;33:25-31. https://doi.org/10.1054/ijom.2003.0448
  5. Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006;66:152-159. https://doi.org/10.1016/j.ijrobp.2006.04.014
  6. Eby LS, Johnson DS, Baker HW. Adenoid cystic carcinoma of the head and neck. Cancer. 1972;29:1160-1168. https://doi.org/10.1002/1097-0142(197205)29:5<1160::AID-CNCR2820290506>3.0.CO;2-1
  7. Tarpley TM, Giansanti JS, Oral Medicine, Oral Pathology, Radiology O. Adenoid cystic carcinoma: analysis of fifty oral cases. Oral Surg Oral Med Oral Pathol. 1976;41:484-497. https://doi.org/10.1016/0030-4220(76)90276-0
  8. Khan AJ, DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, et al. Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer. 2001;96:149-158. https://doi.org/10.1002/ijc.1013
  9. Miglianico L, Eschwege F, Marandas P, Wibault P. Cervico-facial adenoid cystic carcinoma: study of 102 cases. Influence of radiation therapy. Int J Radiat Oncol Biol Phys. 1987;13:673-678. https://doi.org/10.1016/0360-3016(87)90284-7
  10. Sung M-W, Kim KH, Kim J-W, Min Y-G, Seong W-J, Roh J-L, et al. Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2003;129:1193-1197. https://doi.org/10.1001/archotol.129.11.1193
  11. Umeda M, Nishimatsu N, Masago H, Ishida Y, Yokoo S, Fujioka M, et al. Tumor-doubling time and onset of pulmonary metastasis from adenoid cystic carcinoma of the salivary gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88: 473-478. https://doi.org/10.1016/S1079-2104(99)70065-X
  12. Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg. 1997;174:495-498. https://doi.org/10.1016/S0002-9610(97)00153-0
  13. Ampil FL, Misra RP, Surgery M. Factors influencing survival of patients with adenoid cystic carcinoma of the salivary glands. J Oral Maxillofac Surg. 1987;45:1005-1010. https://doi.org/10.1016/0278-2391(87)90154-6
  14. Airoldi M, Fornari G, Pedani F, Marchionatti S, Gabriele P, Succo G, et al. Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res. 2000;20:3781-3783.
  15. Van der Schans E, Knegt P, De Jong P, Van Andel J, De Boer M, Eykenboom W. Adenoid cystic carcinoma of the upper digestive and respiratory tracts. A retrospective study of 59 cases. Clin Otolaryngol Allied Sci. 1985;10:63-67. https://doi.org/10.1111/j.1365-2273.1985.tb01168.x
  16. Huber PE, Debus J, Latz D, Zierhut D, Bischof M, Wannenmacher M, et al. Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?. Radiother Oncol. 2001;59:161-167. https://doi.org/10.1016/S0167-8140(00)00273-5
  17. Kanematsu T, Yohena T, Uehara T, Ushijima C, Asoh H, Yoshino I, et al. Treatment outcome of resected and nonresected primary adenoid cystic carcinoma of the lung. Ann Thorac Cardiovasc Surg. 2002;8:74-77.